The company aims to develop pharmaceuticals and therapeutic products for the treatment of patients, as well as to provide all related services. The company may establish branches in Switzerland and abroad, participate in other companies in Switzerland and abroad, acquire or merge with similar or related companies. Furthermore, the company may acquire, manage and sell industrial property rights, know-how, and intellectual property rights, as well as enter into all transactions and conclude contracts that are suitable to promote the purpose of the company or are directly or indirectly related to it. It may also acquire, hold, encumber and sell real estate in Switzerland and abroad, with the exception of real estate transactions prohibited by the Federal Act on the Acquisition of Real Estate by Persons Abroad (BewG). Additionally, the company may provide financing for its own account or for the account of third parties, as well as grant guarantees and sureties for its subsidiaries and third parties.